CD4 and inflammatory bowel disease: Because of their potent, antigen-specific suppressive capability, CD4+CD25high regulatory T cells have special relevance for the course of disease in IBD and may be promising candidates for immune therapy in a variety of chronic inflammatory diseases, including IBD [47].